Frontiers in liver transplantation
- PMID: 32463145
- DOI: 10.1002/bjs.11714
Frontiers in liver transplantation
Similar articles
-
Liver transplantation for controversial indications: alcoholic liver disease, hepatic cancers, and viral hepatitis.Transplant Proc. 1991 Jun;23(3):1915-6. Transplant Proc. 1991. PMID: 2063426 No abstract available.
-
[Further progress in liver transplantation].Fortschr Med. 1991 Feb 28;109(6):17. Fortschr Med. 1991. PMID: 1646148 German. No abstract available.
-
Liver transplantation for viral hepatitis.Hosp Med. 2005 Jan;66(1):8-12. doi: 10.12968/hmed.2005.66.1.17528. Hosp Med. 2005. PMID: 15686159 Review.
-
Advances and controversies in liver transplantation: hepatocellular cancer, viral hepatitis, and living donor liver transplantation in adults. AASLD/ILTS liver transplantation course. October 27, 2000.Liver Transpl. 2000 Nov;6(6 Suppl 2):S1-80. doi: 10.1053/jlts.2000.2013. Liver Transpl. 2000. PMID: 11142912 No abstract available.
-
Developments in liver transplantation.Gut. 2004 May;53(5):759-68. doi: 10.1136/gut.2003.024927. Gut. 2004. PMID: 15082598 Free PMC article. Review. No abstract available.
Cited by
-
Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study.J Clin Transl Hepatol. 2023 Aug 28;11(4):827-838. doi: 10.14218/JCTH.2022.00297. Epub 2023 Feb 1. J Clin Transl Hepatol. 2023. PMID: 37408815 Free PMC article.
-
Engineering nanotheranostic strategies for liver cancer.World J Gastrointest Oncol. 2021 Oct 15;13(10):1213-1228. doi: 10.4251/wjgo.v13.i10.1213. World J Gastrointest Oncol. 2021. PMID: 34721763 Free PMC article.
-
Liver transplantation for non-resectable colorectal liver metastases: the thin red line.Br J Cancer. 2023 May;128(10):1794-1796. doi: 10.1038/s41416-023-02234-w. Epub 2023 Mar 23. Br J Cancer. 2023. PMID: 36959377 Free PMC article.
-
mTOR inhibitor reduces nontumour-related death in liver transplantation for hepatocellular carcinoma.Mol Biomed. 2024 Mar 10;5(1):9. doi: 10.1186/s43556-024-00170-6. Mol Biomed. 2024. PMID: 38461206 Free PMC article.
References
-
- Khan AS, Adams N, Vachharajani N, Dageforde L, Wellen J, Shenoy S et al. Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: a retrospective cohort study. Int J Surg 2020; 75: 84-90.
-
- Flemming JA, Kim WR, Brosgart CL, Terrault NA. Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology 2016; 65: 804-812.
-
- Molnar MZ, Nair S, Cseprekal O, Yazawa M, Talwar M, Balaraman V et al. Transplantation of kidneys from hepatitis C infected donors to hepatitis C negative recipients: single center experience. Am J Transplant 2019; 19: 3046-3057.
-
- Holmer M, Melum E, Isoniemi H, Ericzon BG, Castedal M, Nordin A et al. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. Liver Int 2018; 38: 2082-2090.
-
- O'Neill S, Srinivasa S, Callaghan CJ, Watson CJ, Dark JH, Fisher AJ et al. Novel organ perfusion and preservation strategies in transplantation - where are we going in the UK? Transplantation 2020: 1. https://doi.org/10.1097/TP.0000000000003106 [Epub ahead of print].
MeSH terms
LinkOut - more resources
Full Text Sources
Medical